Entry |
|
Name |
Fradiomycin sulfate and betamethasone sodium phosphate; Rinderon A (TN) |
Component |
Fradiomycin sulfate [DR: D01618], Betamethasone sodium phosphate [DR: D00972]
|
Remark |
|
Efficacy |
Antibacterial, Anti-inflammatory |
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01CA Corticosteroids and antiinfectives in combination
S01CA05 Betamethasone and antiinfectives
D04246 Fradiomycin sulfate and betamethasone sodium phosphate <JP>
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S03C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
S03CA Corticosteroids and antiinfectives in combination
S03CA06 Betamethasone and antiinfectives
D04246 Fradiomycin sulfate and betamethasone sodium phosphate <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D04246 Fradiomycin sulfate and betamethasone sodium phosphate
132 Otic and nasal agents
1329 Others
D04246 Fradiomycin sulfate and betamethasone sodium phosphate
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Aminoglycoside
D04246 Fradiomycin sulfate and betamethasone sodium phosphate <JP>
|
Other DBs |
|
LinkDB |
|